Njide Okubadejo

Professor of Neurology, College of Medicine, University of Lagos

[Igor Koralnik, MD @IgorKoralnik]

Kudos to @elcolombiano for their reporting on our recent study showing that neurologic manifestations of #LongCovid also affects people in Colombia https://t.co/nC0uA97GR0 @NMNeurology @NUFeinbergMed @NorthwesternMed @AANmember @TheNewANA1

[Igor Koralnik, MD @IgorKoralnik]

It was a pleasure to discuss with @elcolombiano the implications of our collaborative study with CES University in Medellin on #LongCOVID and next steps for cognitive rehabilitation of brain fog.
https://t.co/VaGxD0SSxS
@NMNeurology @NUFeinbergMed @NorthwesternMed @AANmember

[Igor Koralnik, MD @IgorKoralnik]

Congratulations to Drs. Clark, Batra and Liotta for their publication "Impact of healthcare system strain on the implementation of ICU sedation practices and encephalopathy burden during the early COVID-19 pandemic" https://t.co/UBsyCrEphm
@NMNeurology @NUFeinbergMed @AANmember

[Igor Koralnik, MD @IgorKoralnik]

Kudos to "The Guardian Nigeria" for reporting on our study, which reveals that Nigerians suffer from Neurologic manifestations of #LongCOVID. https://t.co/9iLtU7zJoR
@NMNeurology @NUFeinbergMed @NorthwesternMed @AANmember @TheNewANA1

[Igor Koralnik, MD @IgorKoralnik]

Congratulations to Drs. Okubadejo and Akase for their study on the Neurologic Manifestations of #LongCOVID in Nigeria, which was picked up by @ScienceDaily . https://t.co/xUsLuDzGJe
@NMNeurology @NUFeinbergMed @NorthwesternMed @AANmember @TheNewANA1

[Igor Koralnik, MD @IgorKoralnik]

Congratulations to Drs. Akase, Okubadejo and colleagues on their study of the Neurologic manifestations of #LongCovid in Nigeria, published @JNeuroVirology. https://t.co/G2HmHetXck
A first of its kind in sub-Saharan Africa!
@NMNeurology @NUFeinbergMed @AANmember @TheNewANA1

[Njide Okubadejo @Neurobella]

https://t.co/1wsXKcvtZj
@IgorKoralnik @UnilagNigeria @LUTHofficial @CmulNigeria @MobilePunch @TheNationNews @BBCAfrica

[Josu de la Fuente @josudelafuente]

#Amazing achievement today @LUTHofficial : #first ever Bone Marrow Transplant #BMT in West Africa. Congratulations 🙌🏼 all #Nigerian team mentored by @DrAdetolaKassim @VUMChealth & @josudelafuente @ImperialPaeCH @imperialcollege @ImperialPeople

[Njide Okubadejo @Neurobella]

https://t.co/EXe0wL4pZ0

[Njide Okubadejo @Neurobella]

@MichaelOkun Thank you for spotlighting this burning issue! @trapcaf_project @TashMisbah @adpforg @ParkinsonAfrica @omotolathomas8 @DrISubramanian

[Michael Okun @MichaelOkun]

Levodopa or L-Dopa has been available for over 50 years and guess how easy it is to get in Kenya? It is NOT easy. Accessibility of all Parkinson's disease medicines is quite limited across sub-Saharan Africa as Natasha Fothergill-Misbah and colleagues nail it with this important piece in @MDJ_Journal.
Key points:
- The authors point out that lack of levodopa has profound negative health, social and financial consequences.
- They sought the perspective of persons w/ Parkinson's disease, caregivers and neurologists.
- 55 folks w/ Parkinson's, 23 caregivers and 8 neurologists.
- Parkinson's medicines were largely unavailable and unaffordable across Kenya.
- There was financial burden triggered by the need for long-term treatment.
My take: We need to pay more attention to everyone on the planet who has Parkinson's, and we need to get them levodopa. Whether it is through local growing programs w/mucuna or through world coalitions like we did with HIV/AIDS drugs, we need to act. BRAVO to these authors and also kudos to the World Health Organization @WHO for beginning to recognize, mobilize and think about solutions. The time to act is NOW. Check out the 6 actions steps from the recent WHO group. Let's get to work.
https://t.co/z8oYQmtIAq #Parkinsons
Six Action Steps to Address Global Disparities in Parkinson Disease: A World Health Organization Priority
https://t.co/fJBFwpxcvB #PDavengers @ParkinsonDotOrg @PdAvengers @ParkinsonAfrica

[Njide Okubadejo @Neurobella]

@nachogenePD @LARGE_PD @APDAParkinsons Congratulations Nacho and the @LARGE_PD team!

[Dr Tash Fothergill-Misbah @TashMisbah]

Access to medicines for neurological disorders report launch 📣 23rd July 2pm CET! Link to register to attend 👇🏼

[Njide Okubadejo @Neurobella]

Tapping the Brakes on New Parkinson Disease Biological Staging https://t.co/gT8s1yAjrz

[Njide Okubadejo @Neurobella]

President's Letter https://t.co/fZ5b8GSxf2. The WHO IGAP Implementation toolkit launched today will be instrumental to achieving equality of access to levodopa for Parkinson’s. Congratulations to @WHO. @WHONigeria @Fmohnigeria @trapcaf_project @movedisorder @ParkinsonAfrica

[Njide Okubadejo @Neurobella]

Congratulations @WHO on the launch of the IGAP Implementation toolkit! A giant stride promoting equality of access to neurological medicines worldwide, including Parkinson’s medicines! @trapcaf_project @ParkinsonAfrica @AFANeurology @movedisorder @TashMisbah @DrISubramanian

[Njide Okubadejo @Neurobella]

@trapcaf_project @TashMisbah @BritishAcademy_ @NIHRglobal @PolicyNCL @NCL_medscience Congratulations Tash!

[Njide Okubadejo @Neurobella]

A conversation in commemoration of Black History Month. Let’s keep the momentum and lend our voices to ensure inclusion of black ancestry populations in Africa and globally on the agenda to bridge the gaps in Parkinson’s research and access to care. https://t.co/wB93LEsutx